Hem › Myeloproliferativa neoplasmer › New Mexico › Albuquerque
Kliniska studier för Myeloproliferativa neoplasmer i Albuquerque, NM
4 studier för Myeloproliferativa neoplasmer söker deltagare vid platser i och runt Albuquerque (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekryterarFas 2
- University of New Mexico Cancer Center, Albuquerque
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- University of New Mexico Cancer Center, Albuquerque
Project: Every Child for Younger Patients With Cancer
RekryterarObservationsstudie
- Presbyterian Hospital, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Albuquerque
Myeloproliferativa neoplasmer-studier i andra städer
- Houston, TX16 studier
- New York City, NY15 studier
- Boston, MA14 studier
- Milwaukee, WI10 studier
- Miami, FL10 studier
- Durham, NC9 studier
- Baldwin Park, CA9 studier
- Seattle, WA9 studier
- Chicago, IL9 studier
- Portland, OR8 studier
- Cleveland, OH8 studier
- Atlanta, GA8 studier
Andra studier i Albuquerque
- Icke-småcellig lungcancer18 studier
- Bröstcancer17 studier
- Äggstockscancer15 studier
- Cancer (alla typer)14 studier
- Lungcancer14 studier
- Metastaserande cancer12 studier
- Endometriecancer12 studier
- Typ 2-diabetes11 studier
- Hjärt-kärlsjukdom10 studier
- Melanom9 studier
- Akut myeloid leukemi9 studier
- Prostatacancer9 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.